Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02588690 · ClinicalTrials.gov registry record
Beauty from Within Community Screening Project
A clinical trial of Heart Health Screening and Prevention, sponsored by Cedars-Sinai Medical Center.
- Active
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT02588690 is a study of Heart Health Screening and Prevention that is active but no longer recruiting, run by Cedars-Sinai Medical Center. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02588690, a study of Heart Health Screening and Prevention, is active but no longer recruiting, sponsored by Cedars-Sinai Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease (CVD) is the leading cause of death world-wide in women. Despite current medical advances, heart disease is rising in relatively young women. Women access primary care differently than men, most utilizing their Obstetrics-gynecology clinic for primary care services. The recent implementation of the Affordable Care Act (ACA) aims to provide increased access to primary care services, however, women are still not appropriately risk stratified for CVD disease risk. Many women still are not aware that they are at risk for CVD. This is particularly true for the 15-44 year old female age group. Lack of proper risk stratification may be related to women not being properly identified or appropriately referred to preventive cardiovascular services for treatment of traditional risk factors such as diabetes, obesity, hypertension, and dyslipidemia. These traditional risk markers serve as examples of chronic diseases, which are not always recognized in the early stages and therefore not optimally managed. Furthermore, if women are not feeling ill, they are less likely to access their current primary care resources for preventive strategies. Investigators propose to risk stratify women in places where they usually congregate. In addition to convenience, current risk stratification is improved with the recent implementation of the ASCVD risk calculator. Investigators hypothesize that if women were properly risk stratified and referred to appropriate preventive cardiovascular risk clinics, more preventive strategies could be implemented, therefore reducing the amount of unnecessary premature disease in women. To achieve this ambitious goal, investigators propose a three step, demonstration project. The specific aims of this proposal is to: 1. Provide women with CVD risk stratification in places where they locally convene on a daily basis. 2. To evaluate the efficacy of a lay professional to adequately assess CVD risk. 3. To evaluate if assessment of CVD ris
Conditions Studied
Interventions
- PROCEDURE Fingerstick cholesterol test
- OTHER Atherosclerosis Cardiovascular Disease Risk assessment
- PROCEDURE Blood pressure measurement
Study Locations (1)
California
- Cedars-Sinai Women's Heart Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-11 |
| Est. Completion | 2030-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02588690
The ClinicalTrials.gov registry entry for NCT02588690 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Health Screening and Prevention appearing as the primary indexed condition, and to 3 interventions - of which Fingerstick cholesterol test is the first listed.
NCT02588690 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02588690 about?
NCT02588690 is a clinical study titled "Beauty from Within Community Screening Project". Cardiovascular disease (CVD) is the leading cause of death world-wide in women. Despite current medical advances, heart disease is rising in relatively young women. Women access primary care differently than men, most utilizing their Obstetrics-gynecology clinic for primary care services. The recent...
What is the current status of trial NCT02588690?
This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2015-11. Estimated completion is 2030-11.
What conditions does trial NCT02588690 study?
This clinical trial studies the following conditions: Heart Health Screening and Prevention.
What interventions are being tested in trial NCT02588690?
The interventions under investigation include: Fingerstick cholesterol test (PROCEDURE), Atherosclerosis Cardiovascular Disease Risk assessment (OTHER), Blood pressure measurement (PROCEDURE).
Who is sponsoring clinical trial NCT02588690?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02588690 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.